Home › Funds › DARK FOREST CAPITAL MANAGEMENT LP › REGN

DARK FOREST CAPITAL MANAGEMENT LP position in REGN

REGENERON PHARMACEUTICALS · Health Care

DARK FOREST CAPITAL MANAGEMENT LP reported holding 6,744 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$5.1M, representing 0.39% of its reported portfolio and ranking #26 among its reported holdings. DARK FOREST CAPITAL MANAGEMENT LP has disclosed REGN holdings in 6 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)6.74K sh
Reported value held$5.11M
Portfolio Weight0.39%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How DARK FOREST CAPITAL MANAGEMENT LP's REGN position evolved

DARK FOREST CAPITAL MANAGEMENT LP first disclosed a stake in REGN in Q3 2023 at 286 shares (US$235K). The position peaked in Q3 2026 at 6,744 shares, worth US$5.1M. Across 6 filings, DARK FOREST CAPITAL MANAGEMENT LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,744 shares valued at US$5.1M — an increase of 4,197 shares quarter over quarter.. Notable position changes include a 452% increase in Q2 2026 (shares rose 22% over the following quarter), a 165% increase in Q3 2026 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 286 $235.37K New
Q3 2024 635 $667.54K New
Q3 2025 6.07K $3.41M New
Q1 2026 461 $356.19K New
Q2 2026 2.55K $1.59M Add
Q3 2026 6.74K $5.11M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include DODGE & COX (US$3.62B), Dodge & Cox (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has DARK FOREST CAPITAL MANAGEMENT LP held REGN?

DARK FOREST CAPITAL MANAGEMENT LP has disclosed REGN holdings in 6 of the last 13 reported quarters, going back to Q3 2023.

What is DARK FOREST CAPITAL MANAGEMENT LP's current position in REGN?

As of Q3 2026, DARK FOREST CAPITAL MANAGEMENT LP holds 6.74K shares of REGN (REGENERON PHARMACEUTICALS), valued at $5.11M, representing 0.39% of its reported portfolio and ranking #26.

Has DARK FOREST CAPITAL MANAGEMENT LP been buying or selling REGN?

In the latest 13F filing (Q3 2026), DARK FOREST CAPITAL MANAGEMENT LP increased its position in REGN. The position peaked in Q3 2026 at 6.74K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include DODGE & COX, Dodge & Cox, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.